<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39402337</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>FPR1 signaling aberrantly regulates S100A8/A9 production by CD14<sup>+</sup>FCN1<sup>hi</sup> macrophages and aggravates pulmonary pathology in severe COVID-19.</ArticleTitle><Pagination><StartPage>1321</StartPage><MedlinePgn>1321</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1321</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-024-07025-4</ELocationID><Abstract><AbstractText>Excessive alarmins S100A8/A9 escalate the inflammation and even exacerbate immune-driven thrombosis and multi-organ damage. However, the regulatory mechanisms of S100A8/A9 expression in infectious diseases remain unclear. In this study, high-dimensional transcriptomic data analyses revealed a high proportion of CD14<sup>+</sup>FCN1<sup>hi</sup> macrophages within the pulmonary niche post-severe SARS-CoV-2 infection. By constructing the S100-coexpression gene list and supervised module scoring, we found that CD14<sup>+</sup>FCN1<sup>hi</sup> macrophages presented the highest scores of alarmin S100, and possibly served as the trigger and amplifier of inflammation in severe COVID-19. These CD14<sup>+</sup>FCN1<sup>hi</sup> cells lacked the positive regulatory activity of transcription factor PPARγ, and lost their differentiation ability towards mature macrophages. Ex vivo experiments further validated that the epithelial cells with high ORF-3a expression promoted the expression and secretion of S100A8/A9 through ANXA1/SAA1-FPR1 signaling. S100A8/A9 heterodimers, as well as the co-localization of S100A8/A9 with microtubules, were both diminished by the FPR1 inhibitor. Phospho-kinase protein array indicated that STAT3 promoted transcription, and PLC-γ and ERK1/2 pathways were involved in the hetero-dimerization and unconventional secretion of S100A8/A9. Our study highlights the pivotal role of FPR1 signaling in the excessive production of S100A8/A9 and provides a promising target for the prevention and control of severe COVID-19 and post-acute COVID-19 sequelae.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Zhongyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yan</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Changlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Qinghan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shenzhen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hematology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhi-Hui</ForeName><Initials>ZH</Initials><Identifier Source="ORCID">0000-0001-7282-4744</Identifier><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China. luozhihui@wust.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jingjiao</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3861-0261</Identifier><AffiliationInfo><Affiliation>Department of Biology and Genetics, The College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China. zhoujj@wust.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022EHB035</GrantID><Agency>Department of Science and Technology, Hubei Provincial People's Government (Hubei Provincial Department of Science and Technology)</Agency><Country /></Grant><Grant><GrantID>1180011</GrantID><Agency>Hubei Provincial Department of Education (Department of Education, Hubei Province)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D040501">Calgranulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D040502">Calgranulin B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018950">Lipopolysaccharide Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044042">Receptors, Formyl Peptide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000628744">S100A9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000628745">S100A8 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D040501" MajorTopicYN="Y">Calgranulin A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040502" MajorTopicYN="Y">Calgranulin B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018950" MajorTopicYN="Y">Lipopolysaccharide Receptors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="Y">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044042" MajorTopicYN="N">Receptors, Formyl Peptide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402337</ArticleId><ArticleId IdType="pmc">PMC11473795</ArticleId><ArticleId IdType="doi">10.1038/s42003-024-07025-4</ArticleId><ArticleId IdType="pii">10.1038/s42003-024-07025-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO COVID-19 Dashboard. https://covid19.who.int (2023).</Citation></Reference><Reference><Citation>World Health Organization. WHO Director-General’s Opening Remarks at The Media Briefing, 5 May 2023. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing---5-may-2023 (2023).</Citation></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol.21, 133–146 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell185, 881–895.e820 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, L. R. &amp; Perlman, S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses—Are we our own worst enemy? Nat. Rev. Immunol.22, 47–56 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617551</ArticleId><ArticleId IdType="pubmed">34837062</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong, J. G. et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell186, 3882–3902.e3824 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro, A. F. et al. The spatial landscape of lung pathology during COVID-19 progression. Nature593, 564–569 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204801</ArticleId><ArticleId IdType="pubmed">33780969</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad, M. &amp; Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol.20, 355–362 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik, E. et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature606, 585–593 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch, D. et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell184, 6243–6261.e6227 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, D., Han, Z. &amp; Oppenheim, J. J. Alarmins and immunity. Immunol. Rev.280, 41–56 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5699517</ArticleId><ArticleId IdType="pubmed">29027222</ArticleId></ArticleIdList></Reference><Reference><Citation>Danieli, M. G. et al. Alarmins in autoimmune diseases. Autoimmun. Rev.21, 103142 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35853572</ArticleId></ArticleIdList></Reference><Reference><Citation>Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H. &amp; Adolph, T. E. Calprotectin: from biomarker to biological function. Gut70, 1978–1988 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8458070</ArticleId><ArticleId IdType="pubmed">34145045</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott, N. R. et al. S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis. J. Clin. Invest.130, 3098–3112 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7259997</ArticleId><ArticleId IdType="pubmed">32134742</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogl, T. et al. Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation. J. Clin. Invest.128, 1852–1866 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5919817</ArticleId><ArticleId IdType="pubmed">29611822</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi, M. et al. Circulating calprotectin (cCLP) in autoimmune diseases. Autoimmun. Rev.22, 103295 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36781037</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin, A. et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell182, 1401–1418.e1418 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapuis, N. et al. Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients. EBioMedicine80, 104077 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132728</ArticleId><ArticleId IdType="pubmed">35644124</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Q. et al. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell Host Microbe29, 222–235.e224 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7762710</ArticleId><ArticleId IdType="pubmed">33388094</ArticleId></ArticleIdList></Reference><Reference><Citation>Colicchia, M. et al. S100A8/A9 drives the formation of procoagulant platelets through GPIbα. Blood140, 2626–2643 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10653093</ArticleId><ArticleId IdType="pubmed">36026606</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Z. et al. Fate mapping via Ms4a3-expression history traces monocyte-derived cells. Cell178, 1509–1525.e1519 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31491389</ArticleId></ArticleIdList></Reference><Reference><Citation>Evren, E. et al. Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity54, 259–275.e257 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33382972</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider, C. et al. Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. Nat. Immunol.15, 1026–1037 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25263125</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera, A., Siracusa, M. C., Yap, G. S. &amp; Gause, W. C. Innate cell communication kick-starts pathogen-specific immunity. Nat. Immunol.17, 356–363 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4949486</ArticleId><ArticleId IdType="pubmed">27002843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi, M., Borsetti, A., Ciccozzi, M. &amp; Pascarella, S. SARS-Cov-2 ORF3a: mutability and function. Int J. Biol. Macromol.170, 820–826 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836370</ArticleId><ArticleId IdType="pubmed">33359807</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, P. et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med.205, 2235–2249 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556797</ArticleId><ArticleId IdType="pubmed">18809714</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo, F. et al. Cell-surface receptors transactivation mediated by g protein-coupled receptors. Int J. Mol. Sci.15, 19700–19728 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4264134</ArticleId><ArticleId IdType="pubmed">25356505</ArticleId></ArticleIdList></Reference><Reference><Citation>Rammes, A. et al. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem.272, 9496–9502 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9083090</ArticleId></ArticleIdList></Reference><Reference><Citation>Laks, D. R. et al. A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma. Neuro Oncol.20, 764–775 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961175</ArticleId><ArticleId IdType="pubmed">29136244</ArticleId></ArticleIdList></Reference><Reference><Citation>He, B. et al. The metabolic changes and immune profiles in patients with COVID-19. Front Immunol.11, 2075 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485144</ArticleId><ArticleId IdType="pubmed">32983157</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, J. et al. The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates. Eur. J. Clin. Microbiol. Infect. Dis.40, 565–574 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530551</ArticleId><ArticleId IdType="pubmed">33006691</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeffel, G. &amp; Ginhoux, F. Ontogeny of tissue-resident macrophages. Front Immunol.6, 486 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4585135</ArticleId><ArticleId IdType="pubmed">26441990</ArticleId></ArticleIdList></Reference><Reference><Citation>Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity38, 79–91 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3908543</ArticleId><ArticleId IdType="pubmed">23273845</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarov, T., Juarez-Carreño, S., Cox, N. &amp; Geissmann, F. Physiology and diseases of tissue-resident macrophages. Nature618, 698–707 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10649266</ArticleId><ArticleId IdType="pubmed">37344646</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao, M. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med.26, 842–844 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Maus, U. A. et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am. J. Respir. Cell Mol. Biol.35, 227–235 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16543608</ArticleId></ArticleIdList></Reference><Reference><Citation>Misharin, A. V. et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J. Exp. Med.214, 2387–2404 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5551573</ArticleId><ArticleId IdType="pubmed">28694385</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervizaj-Oruqaj, L. et al. Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia. Nat. Commun.15, 87 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10761876</ArticleId><ArticleId IdType="pubmed">38167746</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, F. et al. Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection. Sci. Immunol.7, eabj5761 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35776802</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, F. et al. Fibrinogen-like protein 2 deficiency inhibits virus-induced fulminant hepatitis through abrogating inflammatory macrophage activation. World J. Gastroenterol.28, 479–496 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8790557</ArticleId><ArticleId IdType="pubmed">35125831</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider, C. et al. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog.10, e1004053 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974877</ArticleId><ArticleId IdType="pubmed">24699679</ArticleId></ArticleIdList></Reference><Reference><Citation>Mothes, R. et al. Distinct tissue niches direct lung immunopathology via CCL18 and CCL21 in severe COVID-19. Nat. Commun.14, 791 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9922044</ArticleId><ArticleId IdType="pubmed">36774347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland, T. E., Dyer, D. P. &amp; Allen, J. E. The extracellular matrix and the immune system: a mutually dependent relationship. Science379, eabp8964 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36795835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, K. et al. Regulation of inflammation by members of the formyl-peptide receptor family. J. Autoimmun.85, 64–77 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5705339</ArticleId><ArticleId IdType="pubmed">28689639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, S. C. et al. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1. Free Radic. Biol. Med.106, 254–269 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28232203</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, L. et al. An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell Res.33, 585–603 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10397313</ArticleId><ArticleId IdType="pubmed">37337030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, J. et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg. Microbes Infect.12, 2220578 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse, C. et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J.10.1183/13993003.02441-2018 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8025672</ArticleId><ArticleId IdType="pubmed">31221805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med.29, 1563–1577 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10287567</ArticleId><ArticleId IdType="pubmed">37291214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>